Search
Search Results
-
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
PurposeBreast cancer (BC) is a leading cause of morbidity, disability, and mortality in women, worldwide; triple-negative BC (TNBC) is a subtype...
-
Ductal carcinoma in situ of the breast: immune cell composition according to subtype
Ductal carcinoma in situ of the breast includes several subtypes with a divergent biological behavior. Data regarding the composition of ductal...
-
Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)
The histological classification of breast tumors by the General Rule Committee of the Japanese Breast Cancer Society has been revised in the General...
-
Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer
PurposeTo evaluate the association between preoperative pan-immune inflammation value (PIV) and overall survival (OS) and disease-free survival (DFS)...
-
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS
BackgroundIdentification of women with DCIS who have a very low risk of local recurrence risk (LRR) after breast-conserving surgery (BCS) is needed...
-
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent
ObjectivesAdjuvant chemotherapy (ACT) is recommended for non-organ-confined bladder cancer (BCa) after radical cystectomy (RC) and pelvic lymph node...
-
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast cancer, is characterized by considerable...
-
Why is LCIS Important—Pathological Review
Purpose of ReviewLobular carcinoma in situ (LCIS) encompasses classical LCIS and other rarer and more recently recognised variants, namely...
-
Male patients with unilateral breast symptoms: an optimal imaging approach
ObjectivesTo evaluate the usefulness of bilateral mammography in male patients with unilateral breast symptoms, including investigation of the...
-
Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS
BackgroundAnatomic extent of ductal carcinoma in situ (DCIS) may be uncertain in spite of clinical, pathologic, and imaging data. Consequently...
-
Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study
Invasive micropapillary carcinoma of the breast is a histologic subtype of breast cancer and associated with high incidence of lymphovascular...
-
Plasmocytoid urothelial carcinoma - clinical, histological, immunohistochemical and molecular aspects
Plasmacytoid (PUC) variant is a rare and aggressive form of urothelial cancer representing 1 to 3% of the bladder cancer. The main differential...
-
Sentinel node mapping and ductal carcinoma in situ
BackgroundPure ductal carcinoma in situ (DCIS) is typically unassociated with a risk of regional lymph node involvement. Retrospective series...
-
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas
BK polyomavirus (BKPyV) causes major complications in solid organ transplant recipients but little is known about its role in the development of...
-
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung
Fetal adenocarcinoma of the lung (FLAC) is a rare form of lung adenocarcinoma and was divided into high-grade (H-FLAC) and low-grade (L-FLAC)...
-
Common and rare carcinomas of the thymus
Thymic carcinoma encompasses a diverse group of rare tumors that occur almost exclusively in the prevascular (anterior) mediastinum. Thymic...
-
Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies
Ductal carcinoma in situ (DCIS) is a neoplastic proliferation of mammary ductal epithelial cells confined to the ductal-lobular system, and a...
